Get the Stockscreener App
1.17
4.10%
-0.05
After Hours:
1.17
Bright Minds Biosciences Inc Stock (DRUG) Forecast
The Bright Minds Biosciences Inc (DRUG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.4058, representing a +105.63% increase from the current price of $1.17. The highest analyst price target is $2.406, and the lowest is $2.4057.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DRUG Price Target
Average 1.837
(+57.01% Upside)
Is Bright Minds Biosciences Inc (DRUG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.67 | Neutral |
| STOCH(9,6) | 21.02 | Neutral |
| STOCHRSI(14) | 35.09 | Neutral |
| MACD(12,26) | 0.0195 | Sell |
| ADX(14) | 40.52 | Buy |
| William %R | -92.04 | Buy |
| CCI(14) | -94.49 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2195
Sell
|
1.2046
Sell
|
| MA20 |
1.2047
Sell
|
1.194
Sell
|
| MA50 |
1.1447
Buy
|
1.1604
Buy
|
| MA100 |
1.119
Buy
|
1.1782
Sell
|
| MA200 |
1.3407
Sell
|
1.2811
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, DRUG could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on DRUG, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.67 indicates that DRUG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 21.02 indicates that DRUG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.09 indicates that DRUG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.52 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -94.49 indicates that DRUG is still oversold but not to an extreme extent.
Long-term DRUG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bright Minds Biosciences Inc financial reports and earnings history, Bright Minds Biosciences Inc (DRUG) stock could reach $7.4111 by 2030, $13.39 by 2040 and $34.86 by 2050. See the projected annual prices until 2050 of the Bright Minds Biosciences Inc stock below:
- Bright Minds Biosciences Inc (DRUG) is expected to reach an average price of $4.6772 in 2035, with a high prediction of $4.6731 and a low estimate of $4.7425. This indicates an $299.76% rise from the last recorded price of $1.17.
- Bright Minds Biosciences Inc (DRUG) stock is projected to chart a bullish course in 2040, with an average price target of $13.16, representing an $1,025% surge from its current level. The forecast ranges from a conservative $13.18 to a sky-high $13.39.
- Our analysts predict Bright Minds Biosciences Inc (DRUG) to jump 1,859% by 2045, soaring from $23.34 to an average price of $22.91, potentially reaching $23.54. While $23.34 is the low estimate, the potential upside is significant.
- Bright Minds Biosciences Inc (DRUG) stock is expected to climb by 2050, reaching an average of $35.04, a $2,895% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.86 and $35.09, respectively, highlighting the market's uncertainty.
Bright Minds Biosciences Inc Stock (DRUG) Year by Year Forecast
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2024
Our forecast for DRUG stock price in 2024 now indicates an average price target of $2.1806 with a high forecast of $4.3199 and a low forecast of $0.0413. The average prediction reflects an increase of +86.38% from the last recorded price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $2.3866 | $2.4057 | $2.406 | +103.98% |
| December, 2024 | $2.3114 | $2.2177 | $2.1841 | +97.56% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2025
Bright Minds Biosciences Inc Stock (DRUG) is expected to reach an average price of $1.8103 in 2025, with a high prediction of $2.3526 and a low estimate of $1.2679. This indicates an +54.72% rise from the last recorded price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.3719 | $2.325 | $2.3526 | +102.73% |
| February, 2025 | $2.0894 | $2.2104 | $2.1995 | +78.58% |
| March, 2025 | $0.4492 | $1.8392 | $2.0932 | -61.60% |
| April, 2025 | $1.6626 | $1.2679 | $1.3226 | +42.11% |
| May, 2025 | $1.8143 | $1.6713 | $1.7687 | +55.07% |
| June, 2025 | $1.6021 | $1.8147 | $1.7622 | +36.93% |
| July, 2025 | $1.5755 | $1.5768 | $1.6294 | +34.66% |
| August, 2025 | $1.6704 | $1.6942 | $1.7115 | +42.77% |
| September, 2025 | $1.7256 | $1.7151 | $1.6849 | +47.49% |
| October, 2025 | $1.7621 | $1.6718 | $1.6983 | +50.60% |
| November, 2025 | $1.8409 | $1.7371 | $1.7432 | +57.34% |
| December, 2025 | $1.5177 | $1.5954 | $1.7517 | +29.72% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2026
The predicted value for Bright Minds Biosciences Inc (DRUG) in 2026 is set at an average of $2.3319. Estimates vary from a peak of $4.656 to a trough of $0.00774, indicating an +99.31% surge from the present price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.4201 | $1.5701 | $1.5025 | +21.38% |
| February, 2026 | $1.3611 | $1.4358 | $1.397 | +16.33% |
| March, 2026 | $1.7894 | $1.3617 | $2.2594 | +52.94% |
| April, 2026 | $0.586 | $0.546 | $4.656 | -49.91% |
| May, 2026 | $0.4813 | $0.34 | $1.0673 | -58.86% |
| June, 2026 | $0.0134 | $0.0641 | $0.5426 | -98.85% |
| July, 2026 | $0.1568 | $0.0994 | $0.1218 | -86.60% |
| August, 2026 | $0.0615 | $0.1854 | $0.1055 | -94.74% |
| September, 2026 | $0.184 | $0.00774 | $0.3741 | -84.27% |
| October, 2026 | $0.706 | $0.1264 | $0.929 | -39.66% |
| November, 2026 | $0.7656 | $0.5917 | $1.2456 | -34.56% |
| December, 2026 | $0.5223 | $0.4024 | $1.0783 | -55.36% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bright Minds Biosciences Inc (DRUG) is $2.9259, with a high forecast of $5.789 and a low forecast of $0.0628. This indicates an +150.08% increase from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2175 | $0.1162 | $0.6536 | -81.41% |
| February, 2027 | $0.0978 | $0.0628 | $0.4108 | -91.64% |
| March, 2027 | $3.9371 | $0.1141 | $3.4951 | +236.50% |
| April, 2027 | $4.4915 | $4.1293 | $4.2042 | +283.89% |
| May, 2027 | $5.061 | $4.6589 | $4.9809 | +332.57% |
| June, 2027 | $5.0177 | $5.0283 | $4.9783 | +328.87% |
| July, 2027 | $5.641 | $5.1551 | $5.3172 | +382.13% |
| August, 2027 | $5.4866 | $5.5192 | $5.4292 | +368.94% |
| September, 2027 | $5.7483 | $5.674 | $5.789 | +391.31% |
| October, 2027 | $5.5878 | $5.5155 | $5.5031 | +377.59% |
| November, 2027 | $5.5826 | $5.5801 | $5.5123 | +377.14% |
| December, 2027 | $5.174 | $5.295 | $5.5224 | +342.22% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2028
In 2028, Bright Minds Biosciences Inc (DRUG) is projected to reach an average price of $4.284, with a high projection of $5.1564 and a low estimate of $3.4116. This indicates an +266.16% rise from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4485 | $4.8385 | $5.1564 | +194.74% |
| February, 2028 | $4.3279 | $4.2459 | $4.0779 | +269.91% |
| March, 2028 | $4.6216 | $4.5427 | $4.5974 | +295.01% |
| April, 2028 | $4.3242 | $4.5742 | $4.5321 | +269.59% |
| May, 2028 | $4.191 | $4.2136 | $4.3089 | +258.20% |
| June, 2028 | $4.2006 | $4.2883 | $4.263 | +259.02% |
| July, 2028 | $4.1705 | $4.1842 | $4.1677 | +256.46% |
| August, 2028 | $4.1004 | $4.0527 | $4.0672 | +250.46% |
| September, 2028 | $4.094 | $4.0541 | $4.0087 | +249.91% |
| October, 2028 | $3.7565 | $3.9329 | $3.9834 | +221.07% |
| November, 2028 | $3.4813 | $3.6323 | $3.6428 | +197.55% |
| December, 2028 | $3.3369 | $3.4116 | $3.4368 | +185.21% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2029
The 2029 price forecast for Bright Minds Biosciences Inc Stock (DRUG) is $1.7435 on average, with a high prediction of $3.2564 and a low estimate of $0.2306. This represents an +49.02% increase from the previous price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3485 | $0.513 | $3.2564 | -70.21% |
| February, 2029 | $1.1979 | $0.2306 | $2.8721 | +2.39% |
| March, 2029 | $1.2174 | $1.0027 | $1.1974 | +4.05% |
| April, 2029 | $1.6268 | $1.4947 | $1.4694 | +39.04% |
| May, 2029 | $1.6636 | $1.6489 | $1.6286 | +42.19% |
| June, 2029 | $1.483 | $1.613 | $1.591 | +26.76% |
| July, 2029 | $1.1725 | $1.3116 | $1.3078 | +0.21% |
| August, 2029 | $0.5237 | $0.5592 | $1.0498 | -55.24% |
| September, 2029 | $0.3787 | $0.3213 | $0.4166 | -67.63% |
| October, 2029 | $0.5155 | $0.3581 | $0.2681 | -55.94% |
| November, 2029 | $0.7349 | $0.7829 | $0.7177 | -37.19% |
| December, 2029 | $0.7694 | $0.6623 | $0.6044 | -34.24% |
Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2030
Bright Minds Biosciences Inc Stock (DRUG) is expected to reach an average price of $4.9519 in 2030, with a high forecast of $9.1721 and a low forecast of $0.7317. This signifies an +323.24% surge from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.8531 | $0.7317 | $7.4111 | +571.21% |
| February, 2030 | $8.3223 | $8.0241 | $8.0562 | +611.30% |
| March, 2030 | $8.8065 | $8.4683 | $8.7264 | +652.69% |
| April, 2030 | $8.7006 | $8.7106 | $8.7025 | +643.64% |
| May, 2030 | $9.1946 | $8.7726 | $8.8708 | +685.86% |
| June, 2030 | $8.9549 | $9.0089 | $8.9328 | +665.38% |
| July, 2030 | $9.11 | $9.121 | $9.1721 | +678.63% |
| August, 2030 | $8.8643 | $8.8132 | $8.8222 | +657.63% |
| September, 2030 | $8.7737 | $8.8134 | $8.7034 | +649.89% |
| October, 2030 | $8.2585 | $8.3795 | $8.6922 | +605.85% |
| November, 2030 | $6.4477 | $7.8377 | $8.2196 | +451.09% |
| December, 2030 | $7.2419 | $7.2238 | $6.9919 | +518.97% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):